From: Association of serum Asprosin concentrations with heart failure
Variables | non-HF (N = 103) | HF (N = 103) | P |
---|---|---|---|
Gender (M/F) | 49/54 | 64/39 | 0.069 |
Age (years) | 68.17 ± 5.58 | 70.39 ± 10.66 | 0.063 |
BMI (kg/m2) | 23.60 ± 3.52 | 24.35 ± 3.74 | 0.141 |
SBP (mmHg) | 124.83 ± 18.17 | 127.83 ± 16.37 | 0.215 |
DBP (mmHg) | 72.85 ± 14.35 | 74.8 ± 10.89 | 0.275 |
TC (mmol/L) | 4.79 ± 1.00 | 3.69 ± 1.03* | 0.000 |
TG (mmol/L) | 1.26(0.96,1.90) | 0.91(0.74,1.31)* | 0.000 |
HDL-C (mmol/L) | 1.18 ± 0.27 | 0.97 ± 0.25* | 0.000 |
LDL-C (mmol/L) | 2.79 ± 0.69 | 2.18 ± 0.74* | 0.000 |
Apo A1 (g/L) | 1.35 ± 0.20 | 1.08 ± 0.24* | 0.000 |
Apo B (g/L) | 0.97 ± 0.24 | 0.84 ± 0.34* | 0.001 |
ALT (U/L) | 14.74(11.93,22.3) | 18.09(15.37,20.45) | 0.717 |
AST (U/L) | 14.81(10.23,27.00) | 20.87(16.91,26.35)* | 0.000 |
Cr (µmol/L) | 66.42 ± 11.98 | 82.07 ± 18.17* | 0.000 |
BUN (mmol/L) | 6.58 ± 1.81 | 7.07 ± 2.32 | 0.069 |
FBG (mmol/L) | 5.24 ± 0.98 | 6.24 ± 2.07* | 0.000 |
HbA1C (%) | 5.82 ± 1.36 | 6.57 ± 1.48* | 0.000 |
NT-ProBNP (ng/L) | 63.87(30,102.5) | 1239.16(518,3535)* | 0.000 |
IVS (mm) | 8.54 ± 1.11 | 9.53 ± 1.58* | 0.000 |
LVPW (mm) | 8.46 ± 1.07 | 9.17 ± 1.1* | 0.000 |
LAD (mm) | 34.49 ± 3.87 | 44.48 ± 7.72* | 0.000 |
LVEDD (mm) | 45.21 ± 3.90 | 52.55 ± 8.63* | 0.000 |
E/A | 0.99 ± 0.34 | 1.15 ± 0.71 | 0.058 |
E/e′ | 8(7, 10) | 13(11, 18)* | 0.000 |
LVEF (%) | 61.09 ± 2.51 | 43.5 ± 13.35* | 0.000 |
Prevalence of DM | 12(11.7%) | 42(40.8%)* | 0.036 |
Prevalence of HBP | 35(34%) | 83(80.6%)* | 0.000 |
Prevalence of CAD | 6(5.8%) | 86(83.5%)* | 0.000 |
Dapagliflozin | 7(6.8%) | 29(28.2%)* | 0.000 |
Antiplatelet class | 6(5.8%) | 43(41.7%)* | 0.000 |
Statins | 28(27.2%) | 82(79.6%)* | 0.000 |
ACEI/ARB/ARNI | 20(19.4%) | 74(71.8%)* | 0.000 |
β-blockers | 13(12.6%) | 82(79.6%)* | 0.000 |
CCB | 11(0.7%) | 26(25.2%)* | 0.006 |
Diuretics | 2(1.9%) | 93(90.3%)* | 0.000 |
Nitrates | 1(1%) | 35(34%)* | 0.000 |